Hematopoietic stem cells from poor and good mobilizers are qualitatively equivalent

Transfusion

Volumn 52, Issue 3, 2012, Pages 542-548

  Jiang, Liuyan ^a,b   Malik, Sunny ^a,b   Litzow, Mark ^a,b   Gastineau, Dennis ^a,b   Micallef, Ivana ^a,b   Roy, Vivek ^a,b   Solberg, Lawrence ^a,b   Zubair, Abba C ^a,b  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; DIPEPTIDYL PEPTIDASE IV;

ADULT; AGED; ARTICLE; CELL COUNT; ENGRAFTMENT; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; STEM CELL MOBILIZATION;

ADULT; AGED; ANTIGENS, CD34; FEMALE; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKAPHERESIS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PROSPECTIVE STUDIES; QUALITY CONTROL; TRANSPLANTATION, AUTOLOGOUS; YOUNG ADULT;

EID: 84858298370     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03286.x     Document Type: Article

References (36)

1. Bensinger W, DiPersio JF, McCarty JM,. Improving stem cell mobilization strategies: future directions. Bone Marrow Transplant 2009; 43: 181-95.
2. Fruehauf S, Haas R, Zeller WJ, Hunstein W,. CD34 selection for purging in multiple myeloma and analysis of CD34+ B cell precursors. Stem Cells 1994; 12: 95-102. (Pubitemid 24045793)
3. Sutherland DR, Keating A, Nayar R, Anania S, Stewart AK,. Sensitive detection and enumeration of CD34+ cells in peripheral and cord blood by flow cytometry. Exp Hematol 1994; 22: 1003-10. (Pubitemid 24292893)
4. Kollet O, Dar A, Shivtiel S, Kalinkovich A, Lapid K, Sztainberg Y, Tesio M, Samstein RM, Goichberg P, Spiegel A, Elson A, Lapidot T,. Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nat Med 2006; 12: 657-64. (Pubitemid 43865234)
5. Richman CM, Weiner RS, Yankee RA,. Increase in circulating stem cells following chemotherapy in man. Blood 1976; 47: 1031-9.
6. Heissig B, Hattori K, Dias S, Friedrich M, Ferris B, Hackett NR, Crystal RG, Besmer P, Lyden D, Moore MA, Werb Z, Rafii S,. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 2002; 109: 625-37. (Pubitemid 34628725)
7. Levesque JP, Takamatsu Y, Nilsson SK, Haylock DN, Simmons PJ,. Vascular cell adhesion molecule-1 (CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor. Blood 2001; 98: 1289-97.
8. Petit I, Szyper-Kravitz M, Nagler A, Lahav M, Peled A, Habler L, Ponomaryov T, Taichman RS, Arenzana-Seisdedos F, Fujii N, Sandbank J, Zipori D, Lapidot T,. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 2002; 3: 687-94. (Pubitemid 34752479)
9. Levesque JP, Hendy J, Takamatsu Y, Williams B, Winkler IG, Simmons PJ,. Mobilization by either cyclophosphamide or granulocyte colony-stimulating factor transforms the bone marrow into a highly proteolytic environment. Exp Hematol 2002; 30: 440-9. (Pubitemid 34556735)
10. Semerad CL, Christopher MJ, Liu F, Short B, Simmons PJ, Winkler I, Levesque JP, Chappel J, Ross FP, Link DC,. G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow. Blood 2005; 106: 3020-7. (Pubitemid 41565894)
11. Krause DS, Fackler MJ, Civin CI, May WS,. CD34: structure, biology, and clinical utility. Blood 1996; 87: 1-13. (Pubitemid 26018389)
12. Fruehauf S, Tricot G,. Comparison of unmobilized and mobilized graft characteristics and the implications of cell subsets on autologous and allogeneic transplantation outcomes. Biol Blood Marrow Transplant 2010; 16: 1629-48.
13. Mendrone A Jr, Arrais CA, Saboya R, Chamone Dde A, Dulley FL,. Factors affecting hematopoietic progenitor cell mobilization: an analysis of 307 patients. Transfus Apher Sci 2008; 39: 187-92.
14. Drake M, Ranaghan L, Morris TC, Nolan L, Desai ZR, Irvine AE, Jordan A, Magill K, Price S,. Analysis of the effect of prior therapy on progenitor cell yield: use of a chemotherapy scoring system. Br J Haematol 1997; 98: 745-9. (Pubitemid 27386559)
15. Gandhi MK, Jestice K, Scott MA, Bloxham D, Bass G, Marcus RE,. The minimum CD34 threshold depends on prior chemotherapy in autologous peripheral blood stem cell recipients. Bone Marrow Transplant 1999; 23: 9-13. (Pubitemid 29050172)
16. Perseghin P, Terruzzi E, Dassi M, Baldini V, Parma M, Coluccia P, Accorsi P, Confalonieri G, Tavecchia L, Verga L, Ravagnani F, Iacone A, Pogliani EM, Pioltelli P,. Management of poor peripheral blood stem cell mobilization: incidence, predictive factors, alternative strategies and outcome. A retrospective analysis on 2177 patients from three major Italian institutions. Transfus Apher Sci 2009; 41: 33-7.
17. Bensinger W, Appelbaum F, Rowley S, Storb R, Sanders J, Lilleby K, Gooley T, Demirer T, Schiffman K, Weaver C, Clift R, Chauncey T, Klarnet J, Montgomery P, Petersdorf S, Weiden P, Witherspoon R, Buckner CD,. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 1995; 13: 2547-55.
18. Moskowitz CH, Glassman JR, Wuest D, Maslak P, Reich L, Gucciardo A, Coady-Lyons N, Zelenetz AD, Nimer SD,. Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphoma. Clin Cancer Res 1998; 4: 311-6. (Pubitemid 28122743)
19. Gianni AM,. Where do we stand with respect to the use of peripheral blood progenitor cells? Ann Oncol 1994; 5: 781-4. (Pubitemid 24341868)
20. Yu J, Leisenring W, Bensinger WI, Holmberg LA, Rowley SD,. The predictive value of white cell or CD34+ cell count in the peripheral blood for timing apheresis and maximizing yield. Transfusion 1999; 39: 442-50. (Pubitemid 29233265)
21. Abrahamsen JF, Stamnesfet S, Liseth K, Hervig T, Bruserud O,. Large-volume leukapheresis yields more viable CD34+ cells and colony-forming units than normal-volume leukapheresis, especially in patients who mobilize low numbers of CD34+ cells. Transfusion 2005; 45: 248-53. (Pubitemid 40180143)
22. Zubair AC, Rymer R, Young J, Keeton U, Befort R, Nolot B, Evans C, Bleach T, Torloni A,. Multiple myeloma patients receiving large volume leukapheresis efficiently yield enough CD34+ cells to allow double transplants. J Clin Apher 2009; 24: 6-11.
23. Fruehauf S, Ehninger G, Hubel K, Topaly J, Goldschmidt H, Ho AD, Muller S, Moos M, Badel K, Calandra G,. Mobilization of peripheral blood stem cells for autologous transplant in non-Hodgkin's lymphoma and multiple myeloma patients by plerixafor and G-CSF and detection of tumor cell mobilization by PCR in multiple myeloma patients. Bone Marrow Transplant 2010; 45: 269-75.
24. Zubair AC, Kao G, Daley H, Schott D, Freedman A, Ritz J,. CD34(+) CD38(-) and CD34(+) HLA-DR(-) cells in BM stem cell grafts correlate with short-term engraftment but have no influence on long-term hematopoietic reconstitution after autologous transplantation. Cytotherapy 2006; 8: 399-407. (Pubitemid 44269679)
25. Prabhash K, Khattry N, Bakshi A, Karandikar R, Joshi A, Kannan S, Sastry PS, Parikh P, Kode JA,. CD26 expression in donor stem cell harvest and its correlation with engraftment in human haematopoietic stem cell transplantation: potential predictor of early engraftment. Ann Oncol 2010; 21: 582-8.
26. Zubair AC, Grant R, Wu W, Tun H, Rivera C, Moreno-Aspitia A, Joyce M, Roy V, Colon-Otero G, Solberg LA,. Platelet count is a sensitive predictor of autologous peripheral blood progenitor cell collection yield in previously treated plasma cell disease patients. Transfusion 2008; 48: 1106-14. (Pubitemid 351793480)
27. Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I,. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother 1996; 5: 213-26.
28. Christopherson K,. W, 2nd, Hangoc G, Mantel CR, Broxmeyer HE. Modulation of hematopoietic stem cell homing and engraftment by CD26. Science 2004; 305: 1000-3.
29. Christopherson KW, Cooper S, Hangoc G, Broxmeyer HE,. CD26 is essential for normal G-CSF-induced progenitor cell mobilization as determined by CD26-/- mice. Exp Hematol 2003; 31: 1126-34. (Pubitemid 37329758)
30. Prosper F, Vanoverbeke K, Stroncek D, Verfaillie CM,. Primitive long-term culture initiating cells (LTC-ICs) in granulocyte colony-stimulating factor mobilized peripheral blood progenitor cells have similar potential for ex vivo expansion as primitive LTC-ICs in steady state bone marrow. Blood 1997; 89: 3991-7. (Pubitemid 27220943)
31. Paz H, Wong CA, Li W, Santat L, Wong KK, Chatterjee S,. Quiescent subpopulations of human CD34-positive hematopoietic stem cells are preferred targets for stable recombinant adeno-associated virus type 2 transduction. Hum Gene Ther 2007; 18: 614-26. (Pubitemid 47187093)
32. Cheng T, Rodrigues N, Shen H, Yang Y, Dombkowski D, Sykes M, Scadden DT,. Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science 2000; 287: 1804-8.
33. Danova M, Porta C, Ferrari S, Brugnatelli S, Comolli G, Riccardi A, Ascari E,. Cell cycle status and apoptosis of hematopoietic progenitor cells released into the peripheral blood after taxanes and granulocyte colony-stimulating factor in breast cancer patients. Oncol Rep 2000; 7: 585-9.
34. Jetmore A, Plett PA, Tong X, Wolber FM, Breese R, Abonour R, Orschell-Traycoff CM, Srour EF,. Homing efficiency, cell cycle kinetics, and survival of quiescent and cycling human CD34(+) cells transplanted into conditioned NOD/SCID recipients. Blood 2002; 99: 1585-93. (Pubitemid 34533030)
35. Zubair A, Zahrieh D, Daley H, Schott D, Gribben JG, Freedman A, Ritz J,. Early neutrophil engraftment following autologous BMT provides a functional predictor of long-term hematopoietic reconstitution. Transfusion 2003; 43: 614-21. (Pubitemid 36506358)
36. Zubair AC, Zahrieh D, Daley H, Schott D, Gribben JG, Alyea EP, Schlossman R, Freedman A, Antin JH, Soiffer RJ, Neuberg D, Ritz J,. Engraftment of autologous and allogeneic marrow HPCs after myeloablative therapy. Transfusion 2004; 44: 253-61. (Pubitemid 38236388)